Search This Blog

Tuesday, July 30, 2019

Amgen sales slide as copies dig into Sensipar, Neulasta

Aimovig
Amgen’s CGRP launch Aimovig generated $83 million during the second quarter, helping offset losses of exclusivity that cost the drugmaker. (Amgen)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.